Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations

Christoph Rosak,1 Gabriele Mertes21Specialist for Internal Medicine, Endocrinology and Diabetes, Sachsenhausen Hospital, Frankfurt/Main, Germany; 2Retired, M&uuml;lheim, GermanyAbstract: The alpha-glucosidase inhibitor acarbose has been used for more than 20 years in the management of hyperg...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Rosak C, Mertes G
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/f256b809ffb548318d75dd940d72f69e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f256b809ffb548318d75dd940d72f69e
record_format	dspace
spelling	oai:doaj.org-article:f256b809ffb548318d75dd940d72f69e2021-12-02T07:21:02ZCritical evaluation of the role of acarbose in the treatment of diabetes: patient considerations1178-7007https://doaj.org/article/f256b809ffb548318d75dd940d72f69e2012-10-01T00:00:00Zhttp://www.dovepress.com/critical-evaluation-of-the-role-of-acarbose-in-the-treatment-of-diabet-a11255https://doaj.org/toc/1178-7007Christoph Rosak,1 Gabriele Mertes21Specialist for Internal Medicine, Endocrinology and Diabetes, Sachsenhausen Hospital, Frankfurt/Main, Germany; 2Retired, M&uuml;lheim, GermanyAbstract: The alpha-glucosidase inhibitor acarbose has been used for more than 20 years in the management of hyperglycemia. Owing to its unique mode of action in the gastrointestinal tract, its properties are very different from other antidiabetic medications. Patients on long-term treatment to control a chronic disease are not only interested in good treatment efficacy, but are also even more interested in the safety and side effects of their medications. Significant aspects of acarbose predominantly regarding safety and tolerability in the management of type 2 diabetes and prediabetes are reviewed. It is concluded that acarbose is a convenient long-term treatment option, with benefits for both type 2 diabetics and patients in a prediabetic state.Keywords: acarbose, prediabetes, type 2 diabetes, patient considerations, side effectsRosak CMertes GDove Medical PressarticleSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol 2012, Iss default, Pp 357-367 (2012)
institution	DOAJ
collection	DOAJ
language	EN
topic	Specialties of internal medicine RC581-951
spellingShingle	Specialties of internal medicine RC581-951 Rosak C Mertes G Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
description	Christoph Rosak,1 Gabriele Mertes21Specialist for Internal Medicine, Endocrinology and Diabetes, Sachsenhausen Hospital, Frankfurt/Main, Germany; 2Retired, M&uuml;lheim, GermanyAbstract: The alpha-glucosidase inhibitor acarbose has been used for more than 20 years in the management of hyperglycemia. Owing to its unique mode of action in the gastrointestinal tract, its properties are very different from other antidiabetic medications. Patients on long-term treatment to control a chronic disease are not only interested in good treatment efficacy, but are also even more interested in the safety and side effects of their medications. Significant aspects of acarbose predominantly regarding safety and tolerability in the management of type 2 diabetes and prediabetes are reviewed. It is concluded that acarbose is a convenient long-term treatment option, with benefits for both type 2 diabetics and patients in a prediabetic state.Keywords: acarbose, prediabetes, type 2 diabetes, patient considerations, side effects
format	article
author	Rosak C Mertes G
author_facet	Rosak C Mertes G
author_sort	Rosak C
title	Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
title_short	Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
title_full	Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
title_fullStr	Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
title_full_unstemmed	Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
title_sort	critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
publisher	Dove Medical Press
publishDate	2012
url	https://doaj.org/article/f256b809ffb548318d75dd940d72f69e
work_keys_str_mv	AT rosakc criticalevaluationoftheroleofacarboseinthetreatmentofdiabetespatientconsiderations AT mertesg criticalevaluationoftheroleofacarboseinthetreatmentofdiabetespatientconsiderations
_version_	1718399492980473856

Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations

Ejemplares similares